ACT-281959
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ACT-281959, covering 2018-07-10 to 2018-07-10. Get the full timeline:
Most recent: Clinical Trial Update: Single-ascending Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-281959 / ACT-246475 in Healthy Male Subjects [Phase 1]